A gold standard to distinguish between patients with and without MGMT promotor methylation remains to be defined in IDHwt astrocytomas with pTERTmut, but a combination of different methods seems to be a feasible approach. Here, MGMT is linked to astrocytoma (excluding glioblastoma).